-
Signature
-
Chris Agbe-Davies as Attorney-in-Fact
-
Issuer symbol
-
PFG
-
Transactions as of
-
31 Dec 2025
-
Net transactions value
-
-$3,385,886
-
Form type
-
4
-
Filing time
-
02 Jan 2026, 12:50:37 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| STRABLE-SOETHOUT DEANNA D |
President and CEO |
711 HIGH STREET, DES MOINES |
Chris Agbe-Davies as Attorney-in-Fact |
02 Jan 2026 |
0001278726 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PFG |
Common Stock |
Award |
$1,429,299 |
+38,237 |
+25% |
$37.38 |
191,705 |
31 Dec 2025 |
Direct |
|
| transaction |
PFG |
Common Stock |
Disposed to Issuer |
$3,385,886 |
-38,237 |
-20% |
$88.55 |
153,468 |
31 Dec 2025 |
Direct |
F1, F2 |
| holding |
PFG |
Common Stock |
|
|
|
|
|
62,552 |
31 Dec 2025 |
By Spouse |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PFG |
Common Stock |
Options Exercise |
$581,521 |
-15,557 |
-100% |
$37.38 |
0 |
31 Dec 2025 |
Common Stock |
15,557 |
$37.38 |
Direct |
|
| transaction |
PFG |
Common Stock |
Options Exercise |
$847,778 |
-22,680 |
-100% |
$37.38 |
0 |
31 Dec 2025 |
Common Stock |
22,680 |
$37.38 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: